Pharmaron US Lab Services

Check out our colleague Robert MacNeill's latest #bioanalysis column on the nuanced, sometimes nuisance, nature of quantitative #lcms methodologies, particularly for complex modalities. Read here: https://lnkd.in/edFPDnQu Learn more about Pharmaron's comprehensive global small molecule bioanalysis capabilities, here: https://lnkd.in/e86aEcH6 #Pharmaron #drugdevelopment

Unlocking the Future of Gene and Cell Therapy with Pharmaron’s CGT Safety Assessment Services At Pharmaron, we’re at the forefront of revolutionizing gene and cell therapy (CGT) with our specialized safety assessment services. Our team brings unparalleled expertise and experience, ensuring that our partners’ CGT products meet the highest safety standards. Our comprehensive CGT Safety Assessment includes: - In vitro and in vivo safety evaluations tailored to your project needs - Advanced genetic toxicology and immunogenicity assessments - Customized study designs to support regulatory submissions - End-to-end support from our highly experienced team members   With Pharmaron’s state-of-the-art cGMP biomanufacturing facility and our commitment to excellence, we are your trusted partner in bringing innovative therapies to market. Connect with us to learn more about how our CGT Safety Assessment services: https://lnkd.in/eA4WSZrm #GeneTherapy #CellTherapy #CGT #SafetyAssessment #Pharmaron #Biomanufacturing #Biotech 

Discover Pharmaron's Advanced AAV Gene Therapy Platform! At Pharmaron, we have developed a robust platform process for creating AAV gene therapies, equipped with a highly adaptive toolbox to manage various AAV products and serotypes. Our innovative toolbox allows us to rapidly assess a product’s compatibility with our platform and finely tune multiple parameters for optimal results. Learn more by downloading our poster: Utilising HTPD and DoE to Optimise the Pharmaron Gene Therapy Platform: https://lnkd.in/e9w2Xj7c #GeneTherapy #AAV #Biotechnology #Pharmaron #HTPD #DoE #Innovation

Had an amazing time at the 2024 NE ADME Conference in Boston! A big thank you to The Boston Society for organizing this fantastic event. Our team enjoyed connecting with industry leaders and sharing valuable insights. If you missed us at the conference or couldn’t attend, we'd love to continue the conversation. Learn more about how our innovative approaches can support your projects by scheduling a meeting with our team, here: https://lnkd.in/euGs52Hk #NEADME #Conference #Boston #DrugDiscovery #DMPK #Bioanalysis #RLS #Pharmaron #LifeScience

Essential Insights: AAV Immunogenicity Overview Understanding AAV immunogenicity is pivotal for the progress of gene therapies. Our eBook offers a thorough exploration of this vital subject, backed by our deep experience. At Pharmaron, our team, led by study directors with over 20 years in the immunogenicity field, stands ready to assist. We’ve supported 2 out of the 4 FDA-approved CGT products to phase I clinical trials, demonstrating our commitment to success. Discover how our expertise can support your gene therapy initiatives: https://lnkd.in/d3sbTcVy #AAV #Immunogenicity #GeneTherapy #Pharmaron #CGT #FDAApproval

The Pharmaron team is enjoying today's Lunch & Learn session, "DMPK and Bioanalytical Strategies: Driving Discovery to Regulatory Approval". We are pleased to welcome our attendees, and dive into the DMPK and Bioanalytical strategies that outline the roadmap for driving discovery through regulatory approval. Special thanks to our presenters, Ragu Ramanathan and Mitesh Sanghvi for sharing their valuable insights. If you're attending, we're glad to have met in person for the live presentation. If you missed the event, please scheduled a meeting with our team to learn more, here: https://lnkd.in/e7HeR9RV

Pharmaron is a proud sponsor of the upcoming 2024 NE ADME Conference at Merck Research Laboratories in Boston on June 13th. Join us at our table to learn more about our cutting-edge capabilities. We're looking forward to connecting with industry leaders and discussing how we can support your projects and programs. We hope to see you there. Click here to schedule a meeting with our team: https://buff.ly/3Vpymzp Chelsea Osbrey, Lilly W., Cheng Zhong, Amarjit Girn #NEADME #Conference #Pharmaron #DrugDiscovery #LifeScience #ADME #DMPK #Bioanalysis

Don't miss this opportunity to learn, connect, and enjoy lunch at the PABC in Doylestown, PA! Lunch & Learn Session: DMPK and Bioanalytical Strategies: Driving discovery through regulatory approval Wednesday, June 12th at 12:00 PM EDT PABC, Room 3100, 38005 Old Easton Rd., Doylestown, PA Click here to register: https://buff.ly/4c6hljd Come hungry for knowledge and lunch as Ragu Ramanathan, PhD, VP DMPK Business Operations and Mitesh Sanghvi, PhD, Sr. Director, Regulated Bioanalysis present DMPK and Bioanalytical strategies that outline the roadmap for driving discovery through regulatory approval. #Pharmaron #DMPK #Bioanalysis #drugdiscovery #roadmap #regulatoryapproval #PABC #PA #Pennsylvania #BucksCounty #biotechnology #lunchandlearn

Pharmaron is a proud sponsor of the upcoming 2024 NE ADME Conference at Merck Research Laboratories in Boston on June 13th. Join us at our table to learn more about our cutting-edge capabilities. We're looking forward to connecting with industry leaders and discussing how we can support your projects and programs. We hope to see you there. Click here to schedule a meeting with our team: https://buff.ly/3Vpymzp Chelsea Osbrey, Lilly W., Cheng Zhong, Amarjit Girn #NEADME #Conference #Pharmaron #DrugDiscovery #LifeScience #ADME #DMPK #Bioanalysis

The Pharmaron team had a fantastic time at Wednesday's NE DMDG event. It was great to see this dedicated and innovative team in action. Our VP of DMPK, Ragu Ramanathan, presented on 'High Resolution Mass Spectrometry (HRMS) Based Strategies for Bioanalysis of Antibody-Drug Conjugates (ADCs).' More on Pharmaron's DMPK and Bioanalysis capabilities can be found here: https://buff.ly/3UE89xc Access the latest info sheet on our integrated in vitro and in vivo ADME services - designed to enable rapid decision-making for drug discovery and development programs by clicking here: https://buff.ly/4bSusok #NEDMDG #Pharmaron #Boston #drugdiscovery #DMPK #Bioanalysis #ADME #invitro #invivo